NCT00400231View on ClinicalTrials.gov

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Metabolic Syndrome x
Interventions
DRUG

Study drugs: Metformin and fenofibrate

145mg fenofibrate once/day and 2000mg/day of metformin for arm 3.

DRUG

Study Drug: Metformin

2000mg/day

DRUG

Study Drug: fenofibrate

145mg/day of fenofibrate

DRUG

Metformin and Fenofibrate placebo

placebo metformin and fenofibrate

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Pennsylvania

OTHER